NN, Inc. Completes Sale of Life Sciences Division
Press Release
View printer-friendly version |
<< Back |
NN, Inc. Completes Sale of Life Sciences Division
|
With the proceeds from the transaction, NN expects to reduce its net leverage from approximately 6.1x to approximately 1.8x. Going forward, NN will be well-positioned as a diversified industrial platform with a growth trajectory of approximately J.P. Morgan served as NN's financial advisor and About Except for specific historical information, many of the matters discussed in this press release may express or imply projections of revenues or expenditures, statements of plans and objectives or future operations or statements of future economic performance. These, and similar statements, are forward-looking statements concerning matters that involve risks, uncertainties and other factors which may cause the actual performance of For additional information concerning such risk factors and cautionary statements, please see the section titled "Risk Factors" in the Company's periodic reports filed with the
SOURCE AT ABERNATHY MACGREGOR, Claire Walsh, cw@abmac.com, (212) 371-5999 |